Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
AN INTERVENTIONAL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-08634404 MONOTHERAPY AND IN COMBINATION WITH OTHER ANTICANCER AGENTS IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA
This study is testing a new medicine called PF-08634404 and how it works in adults with advanced Renal Cell Carcinoma (RCC)- a type of kidney cancer that is ei…
Carcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more
PfizerNCT07227415
Phase 2
GU-187: Phase II Trial of Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC all-risk frontline metastatic renal cell carcinoma (mRCC) patients OR any line mRCC …
Metastatic Renal Cell CarcinomaClear-cell Metastatic Renal Cell CarcinomaNeuroendocrine Tumors+1 more
Fox Chase Cancer CenterNCT05263050